ArticleSignal transduction and targeted therapy2022

Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.

Tianhong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.